Patient satisfaction: decreasing the patient “wait time” in the ambulatory care setting  by Savoie, J. et al.
the leaders of the transplant process from the apheresis clinic,
outpatient center, inpatient unit, advanced practice nurse program,
the business manager, and the BMT Business Center meet to
discuss operational issues with the Clinical Administrative Director
(CAD) and the Center Medical Director. Various operational is-
sues across all patient care areas such as daily clinic ﬂow, laboratory
issues, patient discharge issues, and patient education are discussed.
Administrative issues and progress regarding quality improvement
projects are also shared. Weekly meetings encourage the commu-
nication of ideas, provide mutual understanding of each other’s
operations, enhance collaborative plans to improve patient care
and assure follow-through of projects.
Once a month the Department Medical Chairman joins the
leadership team to review ﬁnancials and other pertinent opera-
tional faculty issues. The leadership team also uses this time to
collaborate with other areas in the institution where the BMT
patients are cared for i.e.: the leaders from the Ambulatory Treat-
ment Center join us to discuss operational issues and Physician
Referral Services have joined the team to discuss ways to improve
our relationships with referring physicians. A weekly agenda and
minutes are generated by the CAD and the Administrative Assis-
tant to keep the team focused and directed. The CAD also meets
individually with the managers of the inpatient unit, outpatient
center, and apheresis clinic, as well as, the leaders from the business
center area on a weekly to monthly basis to discuss speciﬁc unit
operational and quality assurance issues as needed. Success is mul-
tifaceted. The team needs to be able to trust each other so as to
negotiate issues that result in outcomes within the team that com-
pliment the entire program. Recognizing and growing the leaders
within the team is important to the dynamics of a program. En-
couraging the building of relationships and creating a culture that
supports the ownership of program outcomes is key to building and
empowering leadership.
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TEAMBUILDING: COMPLEXITY AND CHALLENGE IN ONE OF THE LARG-
EST TRANSPLANT PROGRAMS IN THE COUNTRY
Stary, S.J.1, Adornetto, D.1, Sorensen, S.1, Cruz, E.1, Lyon, V.2 1. UT
MD Anderson Cancer Center, Houston, TX; 2. The Lyon-Group, Hous-
ton, TX
The challenge of developing teambuilding in one of the largest
Blood and Marrow Transplant programs in the country includes
the complexity of the patient’s needs, geographical vastness of the
institution, and the organizational/operational needs of the pro-
gram and Center. The multidisciplinary teams involved in the
patient’s care in the outpatient area include the center nurses,
patient service coordinators, transplant clinical coordinators, pa-
tient access specialists, and patient access coordinators. The mem-
bers of the outpatient transplantation team had developed relation-
ships and silos within their own individual teams in an effort to
provide care to the transplant patient. This has lead to ineffective
collaboration with other team members within the center. A de-
partmental climate survey was administered to all staff members to
measure the effective teamwork amongst members. The results
indicated the need for Centerwide teambuilding, in an effort to
re-establish effective collaboration and trust within and between
the teams.
The administrative team enlisted the services of an outside facil-
itator to assess, coach, and assist in developing techniques to
reestablish communication and trust. Teams were introduced to
the teambuilding concept in a staff meeting resulting in the estab-
lishment of team meetings. A baseline Team Effectiveness Proﬁle
was administered. Each team then participated in the following
workshops; Team behavioral Styles, Team Communication, Team
Conﬂict, and Unblocking Your Team/Managing Change.
The positive feedback from the team members led the BMT
leadership team to establish additional workshops. This has lead to
open communication between the teams and has provided im-
proved collaboration in process improvement projects as evidenced
by observations of daily interaction of staff members.
The next step is to reassess the effectiveness of the workshops
using the Team Effectiveness Proﬁle. The positive feedback from
the staff involved led the administrative staff to continue to pursue
additional workshops within cross-functional teams.
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A REVIEW OF CYTOMEGALOVIRUS INFECTIONS FOLLOWING NONMY-
ELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTS USING CAM-
PATH-1H
Thompson, M., Catlin, C., Rizzieri, D. Duke University Medical Center
Adult Bone Marrow Transplant Center, Durham, NC
The ﬁrst cytomegalovirus (CMV) strain was isolated in cell
cultures in 1956. Since that time, there have been many studies
showing that CMV is one of the most common and potentially life
threatening viral infections in immunosuppressed patients. CMV
disease leads to increased morbidity and mortality rates in bone
marrow transplant patients. Thanks to advancing technology, test-
ing for CMV on the DNA level has enabled us to assess viral loads
and CMV reactivation prior to the onset of CMV disease. The
availability of new antiviral medications has also enabled us to
initiate preemptive antiviral therapy when CMV DNA is ﬁrst
detected. This early detection and treatment has led to a decrease
in end-organ CMV disease and overall mortality from CMV re-
lated infections. Nonmyeloablative stem cell transplantation is a
less toxic approach to allogeneic transplants. Using chemotherapy
regimens with less acute toxicity provide the beneﬁts of allogeneic
stem cells and graft versus malignancy effect to patients who may
not otherwise tolerate a full myeloablative chemotherapy regimen.
This poster will review the incidence and time of onset of CMV
viremia in 125 adult patients participating in a clinical trial using a
nonmyeloablative preparative regimen of 2 grams Cyclophospha-
mide and Fludarabine along with Campath-1H for T-cell deple-
tion of the patient and their donor. This regimen was followed by
allogeneic peripheral stem cell transplant from a matched or mis-
matched donor. Developing a standard for antiviral prophylaxis
post allogeneic stem cell transplantation provides a unique chal-
lange to our health care team and is an area that needs further
research in all transplant centers.
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PATIENT SATISFACTION: DECREASING THE PATIENT “WAIT TIME” IN
THE AMBULATORY CARE SETTING
Savoie, J., Stary, S., Adornetto, D., Evans, K., Peck, N. University of
Texas MD Anderson Cancer Center, Houston, TX
The Blood and Marrow Transplantation patient satisfaction tool
provides a variety of information regarding the patient’s perception
of their health care and members of the health care team. The
rationale for the development of this monthly patient satisfaction
tool was to provide data concerning the perception of the patient
regarding the quality of care, courtesy, efﬁciency of the staff, and
general clinic operations. The patient completes the survey based
on a (1-5) Likert scale. The results of this survey have demon-
strated patient wait time scores with an average of 2.7 out of 5 in
2002 as the primary need for improvement.
In an effort to decrease patient wait time, a task force of staff
members in collaboration with clinic administration, was formed to
determine reasons for lengthy patient wait times and to develop
strategies for improvement. The task force meetings provided the
staff with a sense of ownership in addressing an operational issue.
The task force evaluated and revised the original survey tool,
which was a combined tool for the BMT Center and Apheresis
Clinic. The tool was revised to reﬂect one clinical area. Corrective
actions developed were the standardization of distribution, revision
of physician appointment templates to reﬂect clinic ﬂow, develop-
ment of daily comment cards, informing patient of the reason for
delay, and providing patient with a pager so they may utilize their
time more effectively. Continued monitoring over the ﬁrst 6
months of this year demonstrated little improvement. Therefore,
additional efforts were instituted to decrease the patient’s percep-
tion of their wait time with the implementation of the “15 minute
rule” by speaking with patients regarding their delay, constant
discussion with the staff, administrative rounds through the recep-
tion area speaking with patients, and placards distributed through-
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out the reception area and front desk informing patients their time
is valuable to us.
Recent results have demonstrated an increased satisfaction re-
garding the patient wait times and their perception of why they are
waiting. Continued monitoring of the Patient Satisfaction surveys
on a monthly basis with a weekly review of Comment Cards
provide direction for additional improvements.
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APHERESIS PATIENT SATISFACTION SURVEY: AN ONGOING QUALITY
IMPROVEMENT PROCESS
Sorensen, S.H., Adornetto, D.L., Stary, S., Samaniego, C., Rhodes, B.
M D Anderson Cancer Center, Houston, TX
Patient Satisfaction Surveys (PSS) measure the quality of care
delivered. The Apheresis PSS was a joint survey distributed to
outpatient Blood and Marrow Transplant (BMT) patients and
those in Apheresis. Staff felt the survey had a narrow focus as it
measured the patient’s experience at M D Anderson for that day
only. Additionally, there was no mechanism in place to track the
number of surveys distributed and returned.
Apheresis staff revised the survey to obtain information relevant
to the Apheresis unit. Surveys were distributed monthly, results
trended and discussed in monthly staff meetings. Results were
graphed and displayed on a “story board” using the institutional
quality improvement process of “Plan, Do, Check, Act.” This
allowed for an on-going process of identifying and resolving prob-
lems.
Scores remained high for all categories through out the year,
which gave the staff a good indication of how they were doing. The
lowest score noted was for waiting times after arriving to the
Apheresis unit. It was determined these scores were the lowest for
those patients undergoing Lumbar Punctures (LP). The plan for
distribution was revised and each patient undergoing a LP was
given a PSS to complete. Education was done and the scores were
tracked and trended to identify a change based on the education
provided. Surveys were given to all other patients quarterly. Scores
were also tracked, trended and actions taken based on the results.
All scores remained high and the wait time scores improved for the
LP group.
PSS are now distributed quarterly to all patients and the results
tracked, trended and reported to the staff and the BMT Quality
Improvement Committee.
The next step is validation of the PSS. A resident nurse re-
searcher is assisting the staff in this process. The plan is to reformat
the survey to assure each item only asks one question and to
identify the areas that are important to the patient. The survey will
again be distributed monthly to determine its validity, track and
trend the results, and begin action plans as indicated.
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DEVELOPING NURSING STANDARDS OF PRACTICE FOR BLOOD AND
MARROW (BMT) PATIENTS THROUGH A SHARED GOVERNANCE COUN-
CIL STRUCTURE IN PREPARATION FOR THE FOUNDATION FOR THE
ACCREDITATION OF CELLULAR THERAPIES (FACT) INSPECTION
Causton, C.A., Neumann, J.L., Jacob, R., Tischhauser, T., Weaver, V.
MD Anderson Cancer Center, Houston, TX
The inpatient, unit-based self governance clinical practice coun-
cil was very actively involved in the preparation for the Foundation
for the Accreditation of Cellular Therapies (FACT) inspection at
our large NCI designated cancer center by developing and format-
ting nursing Standards of Practice (SOP). These SOP’s were in
compliance with FACT standards that all relevant nursing proce-
dures have written policies. The clinical practice council met bi-
monthly to develop the standards. Each topic was assigned to a
different member who researched and developed the SOP having
done a literature search with the assistance of the research council
to maintain that our practice was evidence based. The draft was
presented to our council members and discussed until a completed
version was developed. The completed SOP was then formatted
according to FACT standards. Upon completion, it was reviewed
by a committee consisting of the BMT Clinical Coordinator,
Medical Director, Center Administrative Director, Nurse Man-
ager and Assistant Nurse Managers and the BMT Compliance
Ofﬁcer for ﬁnal approval. Once approved, the educational council
introduced the SOP’s to the nursing staff. All the nursing staff were
then required to review and sign off on each SOP. This included all
the units that care for BMT patients throughout the institution (ie.
Intensive care Unit, Protective Environment, Pediatrics-inpatient
unit and outpatient clinic, Outpatient BMT Clinic and Pheresis
Unit). The development and implementation of these standards
was the result of a strong collaborative effort that included other
unit based self-governance councils–the education, communication
and research councils in addition to other areas within the insti-
tution such as the Pediatric Department, the Outpatient Clinic,
Pheresis Unit and the Protective Environment. Our goal was to
ensure the highest quality of care for our BMT patients and
continuity of that care across the entire BMT program.
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SUSPECTED CATHETER RELATED BLOOD STREAM INFECTION (CRBSI)
IN HEMATOLOGY STEM CELL TRANSPLANT PATIENTS: TRACKING
RATES AND OUTCOMES
Haller, S.M., Bevans, M., Curnow, E.S., Gutierrez, D. National In-
stitutes of Health, Bethesda, MD
Central venous catheters (CVC) are a necessity for patients
undergoing treatment for hematological diseases and stem cell
transplant, but place patients at an increased risk for infection. The
incidence of CRBSI varies with clinical factors such as catheter
type and patient’s underlying disease and acuity (CDC, 2002). Due
to a perceived increase in CRBSI, patients undergoing peripheral
blood stem cell transplant or immunosuppressive therapy were
followed for suspected CRBSI over a period of approximately 4
months (March, 2002–July 2002) to determine the prevalence of
CRBSI, the treatments implemented, and outcomes. Adults (N 
105) participating in a clinical trial were admitted to an inpatient
unit with various hematology and oncology diagnoses. Thirty
(29%) were identiﬁed with new fever and/or blood cultures for
suspected CRBSI with no other sources evident. These patients
were evaluated by the vascular access device team and hospital
epidemiology service. Eleven patients (37%) had temporary CVCs
and nineteen (63%) had tunneled CVCs. Patients with tunneled
catheters were more likely to present with signs and symptoms
consistent with CRBSI greater than ﬁfteen days post catheter
insertion as compared to temporary lines (n  14 vs. n  2).
Patients with temporary catheters were more likely to present with
signs and symptoms consistent with CRBSI less than 15 days post
catheter insertion (n  5 vs. n  9). Of the 30 suspected CRBSI,
63% (n  19) had negative CVC blood cultures. Sixteen of these
patients had IV antibiotic therapy initiated upon admission. Ten
(33%) CVCs were removed due to suspected CRBSI; four of them
subsequently had negative blood cultures. This project drew atten-
tion to the important issue of CVC assessment and care within the
interdisciplinary team caring for this population. Policy, proce-
dures, and educational materials were updated to reﬂect current
standards of practice. The CVC standard of practice and patient
teaching tool were revised, and included a new dressing change
technique and schedule. A new tracking method via the occurrence
reporting system was implemented with an organization based
system for continuous quality monitoring for patients with CVCs.
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NON-MYELOABLATIVE STEM CELL TRANSPLANT PATIENT EDUCATION
Johns, A.A., Davis, P.H., Lassiter, M.E., Loftis, J.F., Rowe, K.L. Duke
University Medical Center, Durham, NC
Non-myeloablative stem cell transplantation is being studied in a
number of transplant centers. The reduced intensity of the condi-
tioning regimen offers the opportunity for transplantation to pa-
tients who are older or have comorbid conditions that previously
would have precluded stem cell transplantation (Neiderweiser et al
2003).While this approach holds promise it is still investigational
(Devine et al 2003).
The less intense chemotherapy and/or radiation reduce the in-
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